Evidence map›Paper›PMID 32607948›Full record

ArticleInternational ophthalmology2020

Optical coherence tomography angiography analysis of fabry disease.

Ayse Idil Cakmak, Eray Atalay, Veysel Cankurtaran, Erdoğan Yaşar, Faruk Hilmi Turgut

Abstract read
PubMed Publisher
In one paragraph

Article in International ophthalmology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 23 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Eyes and the heart: what a clinician should know.Heart (British Cardiac Society) · 2023
    Review
  6. Article
  7. Article
  8. Ophthalmic Manifestations in Fabry Disease: Updated Review.Journal of personalized medicine · 2023
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Ayse Idil CakmakTayfur Ata Sokmen Medical School, Department of Ophthalmology, Hatay Mustafa Kemal University, 31040, Antakya, Hatay, Turkey. idilayse@yahoo.com.ORCID http://orcid.org/0000-0003-4377-7314
Eray AtalayDepartment of Ophthalmology, Eskişehir Osmangazi University Medical School, Eskişehir, Turkey.
Veysel CankurtaranTayfur Ata Sokmen Medical School, Department of Ophthalmology, Hatay Mustafa Kemal University, 31040, Antakya, Hatay, Turkey.
Erdoğan YaşarDepartment of Ophthalmology, Aksaray University Medical School, Aksaray, Turkey.
Faruk Hilmi TurgutTayfur Ata Sokmen Medical School, Department of Internal Medicine, Nephrology Clinics, Hatay Mustafa Kemal University, Antakya, Hatay, Turkey.
Mustafa Kemal University · TRAksaray University · TREskişehir Osmangazi University · TR

Funding

Mustafa Kemal Üniversitesi 18.A.006
6 · The paper itself

Abstract

purposeFabry disease (FD) is characterized by a deficiency in α-galactosidase A activity that leads to the cumulative deposition of unmetabolized glycosphingolipids within organs, including the vascular endothelium and the eyes. The purpose of this study was to assess the effects of FD on the retinal microvasculature, foveal avascular zone (FAZ), macular thickness and retinal nerve fiber layer (RNFL) using optical coherence tomography angiography (OCT-A).

methodsTwenty-five patients (14 female and 11 male; mean age 33.16 ± 11.44) with genetically verified FD were compared with 37 age- and sex-matched healthy controls (mean age 32.36 ± 15.54). The vessel density (VD) values of the superficial and deep capillary plexuses (SCP and DCP), the area of the FAZ, the density of radial peripapillary capillaries (RPC), the macular thickness and the retinal nerve fiber layer thickness were measured by OCT-A examination.

resultsThe patients showed significantly lower VD values than controls in the foveal regions of both SCP and the DCP (21.15 ± 5.56 vs. 23.79 ± 4.64 (p = 0.048), 37.92 ± 6.78 vs. 41.11 ± 5.59 (p = 0.048), respectively). The FAZ was significantly larger in the FD group than in the control group (0.3 ± 0.1 vs. 0.24 ± 0.08 (p = 0.011)). No significant difference was identified in measurements of RPC density, peripapillary RNFL thickness or macular thickness between the two groups (p > 0.05 for all).

conclusionDecreased VD and an enlarged foveal avascular area suggest possible changes in the retinal microvasculature of patients with FD. OCT-A can serve as a useful, noninvasive, quantitative tool for diagnosing FD and monitoring its progression.

Indexed as

Fabry DiseaseTomography, Optical CoherenceAdolescentAdultFemaleFluorescein AngiographyFovea CentralisHumansMaleMiddle AgedRetinal VesselsYoung AdultFabry diseaseOptical coherence tomography angiographyPeripapillary retinal nerve fiber layerRadial peripapillary capillariesRetinal vessel density

Identifiers

PMID32607948
OpenAlexW3039290057

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.